Kamke Trent G's Form 4 filing
Lemaitre Vascular Inc (LMAT) · filed Mar 2, 2026
- Accession no.
- 0001193125-26-086289
- Filed
- Mar 2, 2026
- Trade date
- Feb 26-27, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $115.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kamke Trent GCIK 0001365739 | Officer (Senior V. P., Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +1,051 | $0.00 | $0 | 7,812 | Direct | |
| Feb 26, 2026 | Common Stock | MOption exerciseAcquired | +2 | $0.00F2 | $0 | 7,814 | Direct | |
| Feb 26, 2026 | Common Stock | FTax withholdingDisposed | −93 | $113.69 | −$10,573.17 | 7,721 | Direct | |
| Feb 27, 2026 | Common Stock | SSaleDisposed | −1,044 | $110.29 | −$115,142.76 | 6,677 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | MOption exerciseDisposed | −2 | $0.00 | $0 | 6.6 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.